Trial intelligence / Profile preview

Effects of Perampanel on Cognition and EEG in Epilepsy

NCT02900755Phase 4Completed

Sponsor
Seoul National University Hospital
Start
Dec 2016
Primary completion
Apr 2019
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of perampanel in epilepsy, sponsored by Seoul National University Hospital. Primary endpoint: Quantitative EEG change at 6 months. Started Dec 2016; status: completed.

02

Drugs

perampanel
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT02900755.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02900755.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call